Anish Patel

1 month ago | fedscoop.com | Anish Patel

As government agencies continue to expand their reliance on cloud computing to modernize essential services, enhance citizen experiences, and adopt the latest innovations, they are confronting a new set of application development challenges.

Jan 15, 2025 | calbears.com | Anish Patel

This feature originally appeared in the 2024-25 Winter edition of the Cal Sports Quarterly. The Cal Athletics flagship magazine features long-form sports journalism at its finest and provides in-depth coverage of the scholar-athlete experience in Berkeley. Printed copies are mailed four times a year to Bear Backers who give annually at the Bear Club level (currently $600 or more).

Jan 10, 2025 | ng.investing.com | Anish Patel

Anish Patel, the Chief Operating Officer of Enliven Therapeutics, Inc. (NASDAQ:ELVN), a biotechnology company with a market capitalization of $1.06 billion, executed a series of stock transactions as reported in a recent SEC filing. On January 7, Patel sold a total of 28,367 shares of the company’s common stock, generating proceeds of approximately $685,868. The sales occurred at prices ranging from $24.1525 to $24.6008 per share, notably above the current trading price of $21.74.

Oct 15, 2024 | fedscoop.com | Anish Patel

Federal agencies have made great strides in modernizing their digital infrastructure, tapping the power of the cloud and switching to software-as-a-service applications. Yet, by many measures, the aim of those efforts — to improve the public’s and employees’ digital experience — has fallen short of getting agencies where they need to be. Why is that, and what can be done to help agencies achieve the service outcomes the public and employees expect?

Aug 29, 2024 | digitalcommons.library.tmc.edu | Anish Patel |Christine Azzopardi |A Davies |Scott Evans

OBJECTIVE: To determine the optimal KV and mAs settings during CT guided injections in the presence of a total hip arthroplasty so that image quality is maintained whist keeping the dose as low as reasonably achievable. METHODS: A total hip arthroplasty phantom with needles with differing gauges was scanned using different CT parameters (from low dose to high dose) and evaluating if this had any effect on needle conspicuity. Conspicuity was graded from 1 to 3 by 2 independent blinded reviewers.